Sympathetic overdrive and cardiovascular risk in the metabolic syndrome
- PMID: 17345783
- DOI: 10.1291/hypres.29.839
Sympathetic overdrive and cardiovascular risk in the metabolic syndrome
Abstract
Sympathetic neural factors are involved in energy balance as well as in blood pressure control. This represents the background for the hypothesis that an adrenergic overdrive may be implicated in the development and/or progression of the metabolic syndrome. Indirect and direct markers of sympathetic drive have confirmed this hypothesis, by showing the occurrence of an adrenergic activation both at the cardiac and peripheral vascular level. It is likely that this sympathetic dysfunction is triggered by reflex mechanisms (arterial baroreceptor impairment), metabolic factors (insulin resistance), and humoral agents (angiotensin II, leptin). The adrenergic overdrive exerts a number of adverse effects on the cardiovascular system, by favoring the genesis of cardiac hypertrophy, vascular hypertrophy, arterial remodeling and endothelial dysfunction and thereby aggravating the already elevated cardiovascular risk profile of the patient. This carries obvious clinical and therapeutic implications, including the suggestion that sympathetic inhibition should be included among the goals of both pharmacological and non-pharmacological interventions employed in the treatment of the metabolic syndrome.
Similar articles
-
Cardiovascular risk and adrenergic overdrive in the metabolic syndrome.Nutr Metab Cardiovasc Dis. 2007 Jul;17(6):473-81. doi: 10.1016/j.numecd.2007.01.004. Epub 2007 Apr 23. Nutr Metab Cardiovasc Dis. 2007. PMID: 17451923 Review.
-
The 'neuroadrenergic hypothesis' in hypertension: current evidence.Exp Physiol. 2010 May;95(5):581-6. doi: 10.1113/expphysiol.2009.047381. Epub 2009 Dec 11. Exp Physiol. 2010. PMID: 20008032 Review.
-
[The role of the sympathetic nervous system in essential arterial hypertension and organ damage].Ann Ital Med Int. 1995 Oct;10 Suppl:115S-120S. Ann Ital Med Int. 1995. PMID: 8562257 Review. Italian.
-
Heart rate, sympathetic cardiovascular influences, and the metabolic syndrome.Prog Cardiovasc Dis. 2009 Jul-Aug;52(1):31-7. doi: 10.1016/j.pcad.2009.05.007. Prog Cardiovasc Dis. 2009. PMID: 19615491 Review.
-
[Sympathetic nervous factors, pressure variability and organ damage in arterial hypertension].Ann Ital Med Int. 1997 Oct-Dec;12(4):217-22. Ann Ital Med Int. 1997. PMID: 9773576 Review. Italian.
Cited by
-
The potential contribution of stress systems to the transition to chronic whiplash-associated disorders.Spine (Phila Pa 1976). 2011 Dec 1;36(25 Suppl):S226-32. doi: 10.1097/BRS.0b013e3182387fb4. Spine (Phila Pa 1976). 2011. PMID: 22020617 Free PMC article. Review.
-
A Prospective, Randomized Open-Label Study for Assessment of Antihypertensive Effect of Telmisartan Versus Cilnidipine Using Ambulatory Blood Pressure Monitoring (START ABPM Study).Cardiol Res. 2023 Jun;14(3):211-220. doi: 10.14740/cr1476. Epub 2023 May 26. Cardiol Res. 2023. PMID: 37304922 Free PMC article.
-
TNF-α-induced sympathetic excitation requires EGFR and ERK1/2 signaling in cardiovascular regulatory regions of the forebrain.Am J Physiol Heart Circ Physiol. 2021 Feb 1;320(2):H772-H786. doi: 10.1152/ajpheart.00606.2020. Epub 2020 Dec 18. Am J Physiol Heart Circ Physiol. 2021. PMID: 33337962 Free PMC article.
-
Metabolic syndrome and the hepatorenal reflex.Surg Neurol Int. 2016 Sep 13;7:83. doi: 10.4103/2152-7806.190438. eCollection 2016. Surg Neurol Int. 2016. PMID: 27656314 Free PMC article. Review.
-
High blood pressure with elevated resting heart rate: a high risk "Sympathetic" clinical phenotype.Hypertens Res. 2023 Oct;46(10):2318-2325. doi: 10.1038/s41440-023-01394-9. Epub 2023 Jul 27. Hypertens Res. 2023. PMID: 37500715 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical